Gem Aromatics Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs 104.0 Cr (+16.2% YoY) with PAT loss Rs 7.0 Cr; EBITDA margin 7.6%. Standalone PAT Rs 8.9 Cr. Dahej capex (~Rs 265 Cr) capitalised; new specialty molecules ramping.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Q2FY27 consolidated revenue Rs 104.0 Cr (+16.2% YoY) with PAT loss Rs 7.0 Cr; EBITDA margin 7.6%. Standalone PAT Rs 8.9 Cr. Dahej capex (~Rs 265 Cr) capitalised; new specialty molecules ramping.
Gem Aromatics' Q2FY27 press release shows consolidated revenue of Rs 104 Crore but a Rs 7 Crore consolidated loss. Standalone PAT rose to Rs 8.9 Crore.
Gem Aromatics Ltd reported revenue from operations of ₹104 Cr (+16.2% YoY) and a net loss of ₹7 Cr for Q2 FY27.
Gem Aromatics' board meets on 31 October 2026 to approve September quarter and half-year unaudited results. Trading window closes from 1 October until 48 hours after declaration.